Advancements in MIST for BPH: Options, Guidelines, and Patient-Centered Decision-Making
Dean Elterman, MD, covers minimally invasive surgical therapies (MIST) for BPH, including laser therapy, prostatic urethral lift, and others, their impact on BPH management, AUA guidelines, patient selection, and the role of patient preference in choosing between MIST, medication, and surgery.
EP: 1.Comprehensive Insights into the Historical and Modern Treatment Strategies for BPH
Now Viewing
EP: 2.Advancements in MIST for BPH: Options, Guidelines, and Patient-Centered Decision-Making
EP: 3.Optimizing BPH Management: Evaluating MIST Options and Key Treatment Considerations
EP: 4.Real-World Treatment of BPH: Outcomes and Patient Education
EP: 5.Case Study: Diagnosing and Managing BPH in a Male Patient With Urinary Symptoms
EP: 6.Closing
Video content above is prompted by the following:
- Can you please provide a high-level overview of the following available minimally invasive surgical therapies (MIST) options for benign prostate dysplasia (BPH) and how they work?
- Laser therapy
- Prostatic urethral lift procedure
- Water vapor thermal therapy
- Robotic waterjet treatment
- Photoselective vaporization of the prostate
- Any other novel therapeutic options
- How has the emergence of MIST impacted the management of patients with BPH?
- What are the current American Urological Association guidelines/recommendations for MIST?
- Which patients make good candidates for MIST options?
- When/why do you consider a MIST vs surgery (patient prognosis, patient preference, comorbidities)?
- What role does patient preference play in choosing medication vs surgery vs a MIST? Please speak to the importance of shared decision-making.
Recent Videos
Related Content
